Randolph M. Johnson

Portola Pharmaceuticals (United States)United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index3.0kcitations48works2.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Protein Kinase Regulation and GTPase Signaling(8), Nerve injury and regeneration(8), Neurogenesis and neuroplasticity mechanisms(5), Glioma Diagnosis and Treatment(3), Nitric Oxide and Endothelin Effects(3)

Publications48 total

BMC Nephrology·2014· 25 citedOpen Access
Methods in molecular biology·2010· 109 cited
Abstract #LB-205: PG11047, A Polyamine Analog, Induces Potent Antitumor Activity in a Preclinical Model of Non-Small Cell Lung Cancer in Combination with Cisplatin.
Cancer Research·2009
Polyamines, their biochemistry and role in neoplasia.
PubMed·2005· 2 cited
Journal of Neuroscience·2003· 308 citedOpen Access
Journal of Pharmacology and Experimental Therapeutics·2002· 34 cited
Applications of continuous site-directed drug delivery.
PubMed·2002
Archives of Biochemistry and Biophysics·1999· 70 cited
page 1 of 3Next →

Frequent Co-authors

James C. Garrison(6), A. Neil Verity(4), Gregory R. Stewart(4), E Gillis(4), Benjamin S. Carson(4), Michael Guarnieri(4), Derek Maclean(3), Richard M. Eglen(3), Kathleen L. King(3), C.J. Emmett(3), Phillip B. Storm(3), David Fontana(2), Sarah Walter(2), Amos Baruch(2), Shawn T. Alexander(2), Julie Janes(2), Qun Yin(2), Dirk B. Mendel(2), Felix Karim(2), Patricia A. Connelly(2)